Venture Life Adds to Treasury Stock Under Ongoing Share Buyback

Venture Life ( (GB:VLG) ) just unveiled an update.

Venture Life Group, a UK-headquartered international consumer self-care specialist, focuses on proactive healthy longevity through the innovation, development and commercialisation of over-the-counter healthcare products. Its portfolio spans women’s intimate health, ENT care, glucose and energy management and hormonal health, distributed through retail and online channels globally.

The company has repurchased 12,539 ordinary shares at a volume-weighted average price of 70.98 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, Venture Life has 128,860,145 shares in issue, of which 5,011,827 are held in treasury, leaving 123,848,318 voting rights, a figure shareholders will use for regulatory disclosure calculations under FCA transparency rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is an international consumer self-care company operating in the global consumer healthcare sector. Headquartered in the UK, it develops and commercialises products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for hormonal lifecycle support. Its products are typically recommended by pharmacists and healthcare practitioners and are sold via health and beauty retailers, pharmacies, grocery chains, and e-commerce channels worldwide, supplied directly in the UK, Ireland and the U.S. and via distribution partners elsewhere.

Average Trading Volume: 321,957

Technical Sentiment Signal: Buy

Current Market Cap: £87.32M

Learn more about VLG stock on TipRanks’ Stock Analysis page.